Evaluation of clinical effects of oral tamsulosin in reducing urinary retention after spine surgery

Mazandaran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新: 2022年2月7日

试验速览

暂无简介。

•Age over 18 years
•Male and female
•Ability to complete the informed consent form to participate in the study
•Accepting the schedule of participation in the study and the time of surgery and the fact that she must remain in the hospital for at least 1 night after surgery

•Sensitivity or contraindication to the use of tamsulosin
•Severe hypersensitivity to sulfa drugs
•Use of the current alpha-blocker (alphazosin, doxazosin, prazosin, terazosin, verapamil, tamsulosin) or oral alpha agonists, or the initiation of any of these drugs during the start of the intervention phase of the study, which will cause the patient to drop out.
•Take warfarin now
•Use of a Foley catheter, suprapubic catheter or urostomy
•Dialysis patients or patients with less than 200 cc of urine per day
•Predicting the patient's inability to use the drug orally after surgery
•Lack of conscious consent to participate in the study
•Patients who use a Foley catheter chronically
•Patients are expected to be transferred to the ICU after surgery.
•Patients with a history of severe heart failure or major cardiovascular events in the past 6 months
•Use beta-blockers, acetylcholinesterase inhibitors, or drugs that interfere with tamsulosin and betanacol.

发起方